News
Crazy Bulk, the manufacturer of Winsol, was established with the vision to provide the goodness of anabolic steroids in a ...
Rite Aid, the U.S. pharmacy chain, is reportedly weighing another Chapter 11 bankruptcy filing after its recent financial ...
Many investor eyes were on the pharmaceutical industry on Tuesday, and not necessarily for the right reasons. The Trump ...
A new review of clinical trial data finds evidence that GLP-1 drugs can meaningfully reduce dementia risk in people with type ...
Eli Lilly is suing Strive Pharmacy and Empower Pharmacy for compounding tirzepatide, the active ingredient in Zepbound and ...
16d
New Scientist on MSNMicrodosing weight-loss drugs is on the rise – but does it work?There are many claims about the benefits of microdosing weight-loss drugs, from anti-inflammatory effects to extending ...
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Recursion Pharmaceuticals (RXRX – Research ...
If you’re thinking about trying weight loss medication, you probably have a lot of questions about how it works, and how fast ...
Analysts fell to the sidelines weighing in on Keros Therapeutics (KROS – Research Report) and Illumina (ILMN – Research Report) with neutral ...
Eli Lilly sues two compounders over tirzepatide after FDA lifts Zepbound, Mounjaro shortage status in key GLP-1 legal test.
Many investor eyes were on the pharmaceutical industry on Tuesday ... in Eli Lilly's highly popular Zepbound obesity drug. As weight-loss drugs are still rare birds on the market, it's entirely ...
9h
A Day In Our Shoes on MSNWhy Dr. Oz Is a Dangerous Pick to Lead Medicaid: A History of Hype Over HealthcareThe nomination of Dr. Mehmet Oz to lead the Centers for Medicare and Medicaid Services (CMS) has ignited considerable debate.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results